Skip to main content
. 2016 Sep 13;15(1):132. doi: 10.1186/s12933-016-0450-1

Fig. 4.

Fig. 4

Plasma level of ANGPTL3 in relationship to HDL components and function in non-diabetic female subjects and female T2DM patients. Regression was performed between standardized ANGPTL3 and cholesterol (a), apoA-I (b), Serum Amyloid A (c) and the percentage of cholesterol efflux (d) in HDLs in non-diabetic female subjects and female T2DM patients. Estimates express as change in unit with 1-SD increase of ANGPTL3 in non-diabetic subjects and T2DM patients, respectively. §p < 0.0001; ǂp < 0.001; łp < 0.01; * p < 0.05